10 linked-data-"https:"-"https:"-"https:"-"https:" Postdoctoral positions at St Jude Children's Research Hospital
-
. To find out more about our benefits for postdocs, check out this link. The Department of Imaging Sciences is interested in broad areas of imaging, including multi-omics technologies, structural and
-
in Nature , Cancer Cell , Nature Cancer, Lancet Oncology , and Journal of Clinical Oncology . Leveraging our exquisite access to patient material linked to large clinical trial cohorts, we are applying
-
following articles published over the past four years for additional information: Cell 187:205 (2024); Nature 624:154 (2023); Nature 620:200 (2023); Nature 623:1034 (2023); Nature Reviews Immunology
-
analyze data, with minimum supervision, to test specific hypotheses. Expert ability to distill, convey and present complex information in a clear and concise manner both verbally and in writing is essential
-
subtomogram averaging Integrate the structural data with the lab's interaction mapping, proteomics and computational modeling Design and run follow-up cell biology experiments to test mechanistic hypotheses
-
, and computational modeling. They will design and execute experiments, analyze large-scale proteomic data, and interpret results. The individual is expected to lead projects that gravitate
-
the health of children through biomedical research. To apply please include a cover letter, CV and the names and contact information of three references. St. Jude is an Equal Opportunity Employer No Search
-
projects at the interface of cell biology, development, and disease. To apply Please send: a cover letter describing research interests and career goals, a curriculum vitae, and contact information for three
-
discipline The ability to independently design and execute experiments and interpret data Expertise in at least one of the following areas: Super-resolution imaging, including Stimulated Emission Depletion
-
responses to cancer therapies in human induced pluripotent stem cells) data for elucidating molecular mechanisms for health outcomes; and 3) evaluating health disparities through pharmacogenomics